4.5 Article

CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression

Journal

EPIGENOMICS
Volume 11, Issue 10, Pages 1163-1176

Publisher

FUTURE MEDICINE LTD
DOI: 10.2217/epi-2019-0093

Keywords

ceRNAs; circPLK1; circRNAs; MiR-296-5p; miRNAs; PLK1; prognosis; therapy; triple-negative breast cancer; tumor occurrence and metastasis

Funding

  1. National Natural Science Foundation of China [81772961, 81872152, 81702620]

Ask authors/readers for more resources

Aim: To investigate the role of circRNAs in triple-negative breast cancer (TNBC) and the underlying mechanisms. Materials & methods: We performed circRNA microarrays to explore the expression profiles of TNBC cell lines. Experiments in vitro and in vivo were conducted to explore the effects of circPLK1 on tumor proliferation and metastasis as well as the interaction between circPLK1, miR-296-5p and PLK1 in TNBC. Results & conclusion: CircPLK1 was significantly upregulated in TNBC and associated with poor survivals. CircPLK1 knockdown inhibited cell growth and invasion in vitro as well as tumor occurrence and metastasis in vivo. CircPLK1-miR-296-5p-PLK1 axis regulates tumor progression by ceRNA mechanism in TNBC, indicating that circPLK1 may serve as a prognostic factor and novel therapeutic target for TNBC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available